AstraZeneca stock trades at EUR 142.83 with a GBP 187.3 billion market value

Published on 10/12/2026 at 14:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AstraZeneca stock costs EUR 142.83 in trading on October 12, 2026. Its market value is GBP 187.3 billion and P/E is 23.9.

Key points in brief

AstraZeneca stock traded at EUR 142.83 at Lang & Schwarz on October 12, 2026 at 2:06 p.m. CEST.
The company's market capitalization was GBP 187.3 billion and its P/E ratio was 23.9.
The LSE quote was GBp 12,074, within a 52-week range of GBp 9,892 to GBp 15,732.
AstraZeneca's investor calendar lists an ESMO management event for October 26, 2026.

Aquarell einer Cambridge-artigen Flusslandschaft mit Forschungsgebäuden — AstraZeneca plc (ISIN GB0009895292) unterhält einen bedeutenden Forschungsstandort in der britischen Universitätsstadt Cambridge, Illustration mit AI erstellt.

AstraZeneca (ISIN GB0009895292) was trading at EUR 142.83 at Lang & Schwarz on October 12, 2026 at 2:06 p.m. CEST. The market value stood at GBP 187.3 billion, while the valuation measure investors use most closely was a P/E ratio of 23.9.

London quote stays within range

On the London Stock Exchange, AstraZeneca was last at GBp 12,074 on October 12, 2026 at 1:09 p.m. London time. That quote stood between the 52-week low of GBp 9,892 and the 52-week high of GBp 15,732, giving the stock a clear range for judging the latest euro quotation.

Trading volume on the LSE was 530,788 shares at that timestamp, versus an average volume of 3,365,361 shares. The gap shows that the session's activity was below the reported average, even as the company remained one of the largest listed pharmaceutical names by market value.

Valuation trails GSK's multiple

AstraZeneca's P/E ratio of 23.9 was higher than GSK's 14.8, while GSK carried a 4.0 percent dividend yield and a GBP 70.7 billion market value. AstraZeneca's trailing dividend yield was 2.0 percent, placing the two London-listed drugmakers on different income and valuation profiles.

Comparison with peers

AstraZeneca: P/E 23.9, market capitalization GBP 187.3 billion

GSK (LSE, GBp): plus 0.77 percent, P/E 14.8, market capitalization GBP 70.7 billion

Novartis (NYSE, USD): plus 0.45 percent, P/E 22.0, market capitalization USD 273.2 billion

Calendar brings October event

AstraZeneca's investor-relations calendar lists an ESMO management event in Madrid for October 26, 2026, after an ASBMR management event on October 12, 2026, according to AstraZeneca. The dates give the stock a defined schedule for company presentations during the month.

Price holds the market lens

The EUR 142.83 Lang & Schwarz quotation and the GBP 187.3 billion market value frame AstraZeneca as a large-cap pharmaceutical stock, while the 23.9 P/E ratio keeps valuation central to the market view.

The further course of trading is shown by the continuously updated real-time quote of AstraZeneca stock.